BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38064533)

  • 1. Cas9 degradation in human cells using phage anti-CRISPR proteins.
    Meacham Z; de Tacca LA; Bondy-Denomy J; Rabuka D; Schelle M
    PLoS Biol; 2023 Dec; 21(12):e3002431. PubMed ID: 38064533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Listeria Phages Induce Cas9 Degradation to Protect Lysogenic Genomes.
    Osuna BA; Karambelkar S; Mahendra C; Christie KA; Garcia B; Davidson AR; Kleinstiver BP; Kilcher S; Bondy-Denomy J
    Cell Host Microbe; 2020 Jul; 28(1):31-40.e9. PubMed ID: 32325050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
    Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
    Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Anti-CRISPR Locus Repression by a Bi-functional Cas9 Inhibitor.
    Osuna BA; Karambelkar S; Mahendra C; Sarbach A; Johnson MC; Kilcher S; Bondy-Denomy J
    Cell Host Microbe; 2020 Jul; 28(1):23-30.e5. PubMed ID: 32325051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.
    Song G; Zhang F; Tian C; Gao X; Zhu X; Fan D; Tian Y
    Nucleic Acids Res; 2022 Mar; 50(5):2836-2853. PubMed ID: 35188577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent CRISPR-Cas9 inhibitors from
    Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
    Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
    Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of an anti-CRISPR protein, AcrIIA1.
    Ka D; An SY; Suh JY; Bae E
    Nucleic Acids Res; 2018 Jan; 46(1):485-492. PubMed ID: 29182776
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yourik P; Fuchs RT; Mabuchi M; Curcuru JL; Robb GB
    RNA; 2019 Jan; 25(1):35-44. PubMed ID: 30348755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4.
    Li X; Liao F; Gao J; Song G; Zhang C; Ji N; Wang X; Wen J; He J; Wei Y; Zhang H; Li Z; Yu G; Yin H
    Nucleic Acids Res; 2023 Sep; 51(17):9442-9451. PubMed ID: 37587688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
    Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
    FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
    Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
    Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrIIA28 is a metalloprotein that specifically inhibits targeted-DNA loading to SpyCas9 by binding to the REC3 domain.
    Kim GE; Park HH
    Nucleic Acids Res; 2024 Jun; 52(11):6459-6471. PubMed ID: 38726868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides.
    Cui YR; Wang SJ; Chen J; Li J; Chen W; Wang S; Meng B; Zhu W; Zhang Z; Yang B; Jiang B; Yang G; Ma P; Liu J
    Genome Biol; 2020 Feb; 21(1):51. PubMed ID: 32102684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not Your Typical Anti-CRISPR.
    Johnson WE
    Cell Host Microbe; 2020 Jul; 28(1):1-2. PubMed ID: 32645350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; GerĂ³s AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1.
    Zhu Y; Yin S; Li Z
    Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.